INDIA, July 3: Phase-III trials of a vaccine made by India's Bharat Biotech showed it was 93.4% effective against severe symptomatic COVID-19, the firm said on Saturday, a finding that could boost people's acceptance of Covaxin.

DELHI, Jan 24: Indian drugmaker Bharat Biotech’s coronavirus vaccine, which has been authorized for use in the country, proved safe and produced an immune response in a small group of adults aged 18 to 55, according to a study published in The Lancet medical journal.

BENGALURU, Jan 5: A top executive at an Indian biotechnology company defended its COVID-19 vaccine candidate, approved for emergency use by the government, and said it will produce efficacy data from late-stage trials by March.

MUMBAI, Dec 17: An Indian government-backed COVID-19 vaccine showed it was safe and triggered immune responses during an ongoing early-stage trial, the company involved in the study said in a statement on Wednesday.